SONIRE Therapeutics Inc.

CIK 2129660 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for SONIRE Therapeutics Inc..

Recent SEC filings

FiledFormAccession number
Apr 15, 2026D0002129660-26-000001